Collins-Racie; Lisa A.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Collins-Racie; Lisa A..The latest application filed is for "recombinant lubricin molecules and uses thereof".
Company Profile
0.13.33
- Collins-Racie; Lisa A. - Acton MA
Patent Activity
| Patent | Date |
|---|---|
| Recombinant Lubricin Molecules And Uses Thereof App 20150343019 - FLANNERY; Carl Ralph ; et al. | 2015-12-03 |
| Polynucleotides encoding recombinant lubricin molecules and uses thereof Grant 8,987,205 - Flannery , et al. March 24, 2 | 2015-03-24 |
| Polynucleotides Encoding Recombinant Lubricin Molecules And Uses Thereof App 20130196930 - FLANNERY; Carl Ralph ; et al. | 2013-08-01 |
| Polynucleotides encoding recombinant lubricin molecules and uses thereof Grant 8,420,793 - Flannery , et al. April 16, 2 | 2013-04-16 |
| Polynucleotides Encoding Recombinant Lubricin Molecules And Uses Thereof App 20110189731 - FLANNERY; CARL RALPH ; et al. | 2011-08-04 |
| Recombinant lubricin molecules and uses thereof Grant 7,897,571 - Flannery , et al. March 1, 2 | 2011-03-01 |
| Recombinant lubricin molecules and uses thereof Grant 7,893,029 - Flannery , et al. February 22, 2 | 2011-02-22 |
| Recombinant Lubricin Molecules and Uses Thereof App 20100080848 - Flannery; Carl Ralph ; et al. | 2010-04-01 |
| Recombinant Lubricin Molecules And Uses Thereof App 20100074935 - Flannery; Carl Ralph ; et al. | 2010-03-25 |
| Protein Kinase C Zeta As A Drug Target For Arthritis And Other Inflammatory Diseases App 20100062448 - LaVallie; Edward R. ; et al. | 2010-03-11 |
| Recombinant lubricin molecules and uses thereof Grant 7,642,236 - Flannery , et al. January 5, 2 | 2010-01-05 |
| Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases Grant 7,638,482 - LaVallie , et al. December 29, 2 | 2009-12-29 |
| Aggrecanase structure Grant 7,625,731 - Mosyak , et al. December 1, 2 | 2009-12-01 |
| Aggrecanase structure Grant 7,615,363 - Mosyak , et al. November 10, 2 | 2009-11-10 |
| Use Of Rxr Agonists For The Treatment Of Osteoarthritis App 20090209601 - Nagpal; Sunil ; et al. | 2009-08-20 |
| Use of LXR agonists for the treatment of osteoarthritis App 20090012053 - Nagpal; Sunil ; et al. | 2009-01-08 |
| Secreted proteins and polynucleotides encoding them App 20080139452 - Jacobs; Kenneth ; et al. | 2008-06-12 |
| Secreted proteins and polynucleotides encoding them Grant 7,344,861 - Jacobs , et al. March 18, 2 | 2008-03-18 |
| Recombiant lubricin molecules and uses thereof App 20070191268 - Flannery; Carl Ralph ; et al. | 2007-08-16 |
| Aggrecanase Structure App 20070178574 - Mosyak; Lydia ; et al. | 2007-08-02 |
| Truncated aggrecanase molecules App 20070161046 - Georgiadis; Katy E. ; et al. | 2007-07-12 |
| Aggrecanase molecules App 20070128616 - Corcoran; Christopher J. ; et al. | 2007-06-07 |
| Truncated aggrecanase molecules Grant 7,223,858 - Georgiadis , et al. May 29, 2 | 2007-05-29 |
| Aggrecanase Structure App 20070105207 - Mosyak; Lydia ; et al. | 2007-05-10 |
| Truncated aggrecanase molecules Grant 7,150,983 - Georgiadis , et al. December 19, 2 | 2006-12-19 |
| Secreted proteins and polynucleotides encoding them App 20060269957 - Jacobs; Kenneth ; et al. | 2006-11-30 |
| Truncated aggrecanase molecules App 20060257989 - Georgiadis; Katy E. ; et al. | 2006-11-16 |
| Secreted proteins and polynucleotides encoding them App 20060177904 - Jacobs; Kenneth ; et al. | 2006-08-10 |
| Aggrecanase molecules Grant 7,078,217 - Corcoran , et al. July 18, 2 | 2006-07-18 |
| Secreted proteins and polynucleotides encoding them App 20060063227 - Jacobs; Kenneth ; et al. | 2006-03-23 |
| Truncated ADAMTS molecules App 20050277175 - LaVallie, Edward R. ; et al. | 2005-12-15 |
| Proteases and uses thereof App 20050260733 - LaVallie, Edward R. ; et al. | 2005-11-24 |
| Secreted protein and polynucleotides encoding them App 20050250180 - Jacobs, Kenneth ; et al. | 2005-11-10 |
| Secreted proteins and polynucleotides encoding them App 20050003491 - Jacobs, Kenneth ; et al. | 2005-01-06 |
| Protein kinase C zeta as a drug target for arthritis and other inflammatory diseases App 20040259136 - LaVallie, Edward R. ; et al. | 2004-12-23 |
| Truncated aggrecanase molecules App 20040054149 - Georgiadis, Katy E. ; et al. | 2004-03-18 |
| Aggrecanase molecules App 20040044194 - Corcoran, Christopher J. ; et al. | 2004-03-04 |
| Secreted proteins and polynucleotides encoding them App 20040038276 - Jacobs, Kenneth ; et al. | 2004-02-26 |
| Novel proteins App 20030166044 - Jacobs, Kenneth ; et al. | 2003-09-04 |
| Secreted Proteins And Polynucleotides Encoding Them App 20030096951 - JACOBS, KENNETH ; et al. | 2003-05-22 |
| Secreted proteins and polynucleotides encoding them App 20030044935 - Jacobs, Kenneth ; et al. | 2003-03-06 |
| Human Chordin-related Proteins And Polynucleotides Encoding Them App 20020197666 - JACOBS, KENNETH ; et al. | 2002-12-26 |
| Secreted proteins and polynucleotides encoding them App 20020193567 - Jacobs, Kenneth ; et al. | 2002-12-19 |
| Secreted proteins and polynucleotides encoding them App 20020065394 - Jacobs, Kenneth ; et al. | 2002-05-30 |
| Secreted proteins and polynucleotides encoding them App 20010039335 - Jacobs, Kenneth ; et al. | 2001-11-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 